ICON Completes the Acquisition of Clinical Research Management, Inc.
Acquisition extends ICON’s presence in the market for government sponsored research and enhances capabilities in Vaccines and Infectious Disease
ICON Forms Strategic Alliance With Boston Clinical Research Institute
Alliance Enhances ICON’s Scientific Expertise and Access to Investigators
ICON Reports Second Quarter 2016 Results
In the second quarter net revenue grew 5.7% year on year to $410.6 million.
ICON to Acquire Clinical Research Management, Inc.
ClinicalRM provide full service and functional research solutions to a broad range of US government agencies.
ICON Sponsored Research Validates Shorter and Simpler Patient Consent
Opportunities to reduce content on consent forms by over 80% and using video formats can improve patient comprehension and engagement
ICON and Pfizer Win Clinical Research Team of the Year
ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards
ICON Reports Fourth Quarter and Full Year 2015 Results and Issues 2016 Earnings Guidance
In the fourth quarter net revenue grew 3.4% year on year to $403.3 million from $390
ICON selected by Genomics England
ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases
ICON Accelerates Site Activation Timelines by up to 25%
ICON announce that it has accelerated its study start-up timelines globally and has achieved a reduction of mean start-up cycle times by up to 25%
ICON Acquires PMG Research Inc.
Acquisition enhances ICON’s site and patient engagement capabilities